Ryan Nipp to Liver Neoplasms
This is a "connection" page, showing publications Ryan Nipp has written about Liver Neoplasms.
Connection Strength
0.263
-
Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials. ESMO Open. 2020 08; 5(4).
Score: 0.156
-
Should FOLFOXIRI plus bevacizumab Be the standard first-line therapy in metastatic colorectal cancer? Oncologist. 2015 Mar; 20(3):236-8.
Score: 0.107